2025 annual financial data
Amylyx Pharmaceuticals 2025 Net income growth
Direct answer
Net income growth was 52.03%.
Operating income was -153,291,000 USD and net income was -144,735,000 USD.
Operating cash flow was -123,343,000 USD.
Get free Amylyx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -153,291,000 USD
- Net income
- -144,735,000 USD
- Operating cash flow
- -123,343,000 USD